A Study to Assess the Safety of SAB-176 to Prevent the Flu, Given IM in Healthy Adults Compared With Placebo

NCT06435936 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

PHA1A

Interventions

DRUG: Single Ascending Dose of SAB-176
DRUG: Single Ascending Dose of Placebo

Sponsor

SAb Biotherapeutics, Inc.